The prognostic factors in 384 patients with FIGO 2014 stage IB cervical cancer: What is the role of tumor size on prognosis?

Yüksel, Dilek; Şahin, Ediz Karataş; Ünsal, Mehmet; Çakır, Caner; Kılıç, Çiğdem; Cömert, Günsu Kimyon; Korkmaz, Vakkaş; Türkmen, Osman; Turan, Taner

doi:10.1016/j.ejogrb.2021.09.028

Cited by 3 publications

(2 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Year of diagnosis and histological grade were excluded from the model because they were not signi cantly associated with OS in patients by multivariate regression analysis. This nding proved that clinical stage and tumor size were the two greatest contributors to nomogram, which was consistent with previous studies (29)(30)(31). Later clinical staging results in lower 3-and 5-year OS among patients with cervical cancer (32).…”

Section: Discussionsupporting

confidence: 91%

A novel prognostic model for cervical cancer patients with lymph node metastases: based on SEER database and an independent cohort

Liu

Wang

Song

et al. 2022

Preprint

View full text Add to dashboard Cite

Introduction: Cervical cancer with lymph node metastasis (LNM) has a poor prognosis, but the prognosis of patients varies among individuals to a great extent and depends on diverse factors. This study attempted to develop and externally validate a prognostic model based on risk factors to predict the probability of survival of patients with cervical cancer with LNM. Methods A population-based cohort with 4238 participants diagnosed with cervical cancer with LNM between 2000 and 2016 from the Surveillance, Epidemiology, and End Results database was used to select prognostic variables for inclusion in our model. Model performance was validated internally and externally using the concordance index (C-index), areas under the curve (AUC) of receiver operating characteristic (ROC) curves, calibration curves, and decision curve analyses (DCA). Kaplan–Meier survival curve was used to validate the risk stratification capability of the established model. Results Prognostic factors included marital status, age, pathological subtype, clinical stage, tumor size, surgical treatment, radiotherapy, and chemotherapy (all P < .05). The C-index (0.736, 0.727, and 0.701 for the training, internal validation, and external validation cohorts) and AUC values of the 3- and 5-year ROC curves (0.781 and 0.777 for the training cohort, 0.78 and 0.759 for the internal validation cohort, and 0.728 and 0.74 for the external validation cohort) demonstrated the satisfactory discrimination and excellent accuracy of the nomogram. Calibration plots showed the favorable agreement between the predicted and observed probabilities, and DCA indicated good clinical benefits. The nomogram-based risk stratification successfully discriminated patients into low-, intermediate-, and high-risk populations. Conclusion An easy-to-use online website of the dynamic nomogram was provided which could help predict overall survival of cervical cancer with LNM.

show abstract

Section: Discussionsupporting

confidence: 91%

A novel prognostic model for cervical cancer patients with lymph node metastases: based on SEER database and an independent cohort

Liu

Wang

Song

et al. 2022

Preprint

View full text Add to dashboard Cite

show abstract

“…This may be related to the fact that the cancer cells of squamous cell carcinoma patients have invaded into the muscle layer, the distance from the radiation source is far, patients with advanced staging have increased tumor uncontrollability, and patients with lymph node metastasis have wider tumor distribution ( 16 , 17 ). Yüksel et al ( 18 ), Ramlov et al ( 19 ) found that case typing, tumor size, lymph node metastasis, etc. are all risk factors for the prognosis of patients with medium-term and advanced cervical cancer.…”

Section: Discussionmentioning

confidence: 99%

Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy Combined with Intracavitary Posterior Radiotherapy for the Treatment of Medium-Term and Advanced Cervical Cancer: Efficacy, Safety and Prognostic Factors

Yu¹,

Zhou

2022

Front. Surg.

View full text Add to dashboard Cite

ObjectiveTo explore the efficacy, safety, and prognostic factors of intensity modulated radiation therapy (IMRT) and three dimensional conformal radiation therapy (3D-CRT) combined with intracavitary posterior radiotherapy for medium-term and advanced cervical cancer.MethodsRetrospectively analyze the clinical data of 104 patients with medium-term and advanced cervical cancer who were treated in the radiotherapy department of our hospital from September 2015 to March 2017. According to the different radiotherapy techniques, they were divided into the IMRT combined with intracavitary posterior radiotherapy group (n = 52) and the 3D-CRT combined with intracavitary posterior radiotherapy group (n = 52). Observe and compare the short-term efficacy, occurrence of adverse reactions and overall survival rate of the two groups. The clinicopathological characteristics of the survival group and the death group were compared, and univariate analysis and multiple logistic regression models were used to analyze the relationship between the clinicopathological characteristics and the patient’s prognosis.ResultsThe total effective rate of IMRT combined with intracavitary posterior radiotherapy group was 96.15%, which was higher than that of 3D-CRT combined with intracavitary posterior radiotherapy group (88.46%), but the difference was not statistically significant (p > 0.05). The incidence of digestive system injury, thrombocytopenia, and radiation proctitis in the IMRT combined intracavitary posterior radiotherapy group was lower than that of the 3D-CRT combined intracavitary posterior radiotherapy group, and the differences were statistically significant (p < 0.05). The prognosis and survival of the two groups of patients were similar, and the difference was not statistically significant (p > 0.05). Pathological classification, clinical stage, and lymph node metastasis are independent influencing factors of 3-year prognosis in patients with medium-term and advanced cervical cancer (p < 0.05).ConclusionIMRT combined with intracavitary posterior radiotherapy is equivalent to 3D-CRT combined with intracavitary posterior radiotherapy, but it can reduce the incidence of adverse reactions in patients with medium-term and advanced cervical cancer, and has higher safety. Pathological typing, clinical staging, Lymph node metastasis were independent factor affecting the prognosis of patients. In clinical treatment, IMRT combined with intracavitary posterior radiotherapy is more recommended as a treatment plan for patients with medium-term and advanced cervical cancer.

show abstract

Role of MRI in the Assessment of Cervical Cancer

Cucinella

Zaccaria

et al. 2023

Seminars in Ultrasound, CT and MRI

View full text Add to dashboard Cite

The prognostic factors in 384 patients with FIGO 2014 stage IB cervical cancer: What is the role of tumor size on prognosis?

Cited by 3 publications

References 34 publications

A novel prognostic model for cervical cancer patients with lymph node metastases: based on SEER database and an independent cohort

A novel prognostic model for cervical cancer patients with lymph node metastases: based on SEER database and an independent cohort

Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy Combined with Intracavitary Posterior Radiotherapy for the Treatment of Medium-Term and Advanced Cervical Cancer: Efficacy, Safety and Prognostic Factors

Role of MRI in the Assessment of Cervical Cancer

Contact Info

Product

Resources

About